TY - JOUR
T1 - European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours
AU - Rinke, Anja
AU - Ambrosini, Valentina
AU - Dromain, Clarisse
AU - Garcia-Carbonero, Rocio
AU - Haji, Amyn
AU - Koumarianou, Anna
AU - van Dijkum, Els Nieveen
AU - O'Toole, Dermot
AU - Rindi, Guido
AU - Scoazec, Jean Yves
AU - Ramage, John
N1 - Publisher Copyright:
© 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.
PY - 2023/6/1
Y1 - 2023/6/1
N2 - This ENETS guidance paper, developed by a multidisciplinary working group, provides an update on the previous colorectal guidance paper in a different format. Guided by key clinical questions practical advice on the diagnosis and management of neuroendocrine tumours (NET) of the caecum, colon, and rectum is provided. Although covered in one guidance paper colorectal NET comprises a heterogeneous group of neoplasms. The most common rectal NET are often small G1 tumours that can be treated by adequate endoscopic resection techniques. Evidence from prospective clinical trials on the treatment of metastatic colorectal NET is limited and discussion of patients in experienced multidisciplinary tumour boards strongly recommended. Neuroendocrine carcinomas (NEC) and mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) are discussed in a separate guidance paper.
AB - This ENETS guidance paper, developed by a multidisciplinary working group, provides an update on the previous colorectal guidance paper in a different format. Guided by key clinical questions practical advice on the diagnosis and management of neuroendocrine tumours (NET) of the caecum, colon, and rectum is provided. Although covered in one guidance paper colorectal NET comprises a heterogeneous group of neoplasms. The most common rectal NET are often small G1 tumours that can be treated by adequate endoscopic resection techniques. Evidence from prospective clinical trials on the treatment of metastatic colorectal NET is limited and discussion of patients in experienced multidisciplinary tumour boards strongly recommended. Neuroendocrine carcinomas (NEC) and mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN) are discussed in a separate guidance paper.
KW - colorectal
KW - endoscopic treatment
KW - guideline
KW - neuroendocrine tumour
KW - rectal carcinoid
UR - http://www.scopus.com/inward/record.url?scp=85163223034&partnerID=8YFLogxK
U2 - 10.1111/jne.13309
DO - 10.1111/jne.13309
M3 - Article
C2 - 37345509
AN - SCOPUS:85163223034
SN - 0953-8194
VL - 35
JO - Journal of Neuroendocrinology
JF - Journal of Neuroendocrinology
IS - 6
M1 - e13309
ER -